Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
17
NCT06193902
LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours.
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 13, 2023
Completion: May 31, 2029
Loading map...